Can Adipose Tissue Browning Become a New Frontier in Cardiometabolic Prevention?
Atherosclerosis posted on LinkedIn:
”Can adipose tissue browning become a new frontier in cardiometabolic prevention?
Emerging research is uncovering how browning of white adipose tissue (AT) – the conversion to a more metabolically active, thermogenic phenotype – could improve both metabolic and cardiovascular health.
- Pro-inflammatory pathways (NLRP3, TLR4, NF-κB) inhibit browning
- Anti-inflammatory signals (IL-4, IL-13, M2 macrophages) promote it, enhancing insulin sensitivity and glucose tolerance
- Mitochondrial effectors – UCP-1 and PGC1-α – are key drivers of thermogenesis
- Experimental interventions (ASK-1 knockout, nitrate, melatonin) improved endothelial function, atherosclerosis, and liver steatosis
While evidence is still largely preclinical, these findings suggest that targeting adipose tissue inflammation and mitochondrial function could open new therapeutic avenues for atherosclerotic cardiovascular disease.
Could “browning” therapies become part of the next generation of cardiometabolic treatments?”
Read the full article here.
Title: Molecular mechanisms linking adipose tissue browning to reduced cardiovascular risk
Authors: Ana Checa-Rosa, Luis D’Marco
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal